https://cordycepininhibitor.co....m/local-pharmacy-ind
Interestingly, accessing the International Microarray Innovations in Leukemia (MILE) research team, we detected that both EHMT1 and EHMT2 tend to be overexpressed in ALL. Much more important, we determined that inhibition of EHMT1/EHMT2 dramatically reduced Jurkat mobile viability in a dose-dependent manner. Consequently, we observed that inhibition of EHMT1/EHMT2 promoted Jurkat cellular death, that has been combined with increased expression of P53, TP73, BAX, and MDM4. These outcomes
Like
Comment
Share
